Rare Case Report: Guillain–Barré Syndrome As A Neurological Complication In Patients With Dengue Fever

R Zhafira Arrum Prabapatitis; Muhammad Adam Prabasunu

doi:10.59141/-.v8i2.480

Authors

R Zhafira Arrum Prabapatitis Universitas Islam Indonesia
Muhammad Adam Prabasunu Universitas Islam Indonesia

DOI:

https://doi.org/10.59141/-.v8i2.480

Keywords:

Guillain–Barre syndrome, dengue fever, neurological complications

Abstract

Dengue virus infection has many complications, one of the rare neurological complications is Guillain-Barre syndrome (GBS). Dengue virus is classified into four serotypes, namely DENV-1, DEN-2, DEN-3 and DEN-4, while the most frequent causes of neurological complications are DEN-2 and DEN-3. This case report aims to a rare case of Guillain-Barré syndrome as a neurological complication of dengue fever and highlight the importance of early diagnosis and management. Case Reports: A 46-year-old man has had two main complaints of weak limbs, tingling and numbness since the last 5 days, followed by complaints of both weak arms, tingling and numbness since the last 4 days, accompanied by heartburn pain and double vision. The patient had a previous hospitalization history 10 days ago with a diagnosis of dengue fever with a positive NS 1 result. The physical examination found that the lateralized muscle strength of the sinistra and physiological reflexes were reduced in both legs and both arms, pain sensations and palpable sensations were reduced. The results of the examination are in accordance with the results of the ENMG examination, namely the AMSAN type GBS. Currently, patients are diagnosed with GBS as a sequel to dengue fever infection. The pathogenesis of GBS caused by the dengue virus is mediated by the immune system against the DEN serotype that affects peripheral nerves. Based on previous case reports, GBS cases are one of the neurological complications of dengue fever. GBS is one of the neurological complications in patients with dengue fever.

Downloads

Download data is not yet available.

References

[1] Djaafara B, Elyazar IRF, Surya A, Silalahi FSM, Handito A, Aryani D, et al. Estimating dengue force of infection from age-stratified surveillance data in Java, Indonesia. J R Soc Interface 2025;22. https://doi.org/10.1098/rsif.2025.0445.

[2] Gulia M, Dalal P, Gupta M, Kaur D. Concurrent Guillain-Barré syndrome and myositis complicating dengue fever. BMJ Case Rep 2020;13. https://doi.org/10.1136/bcr-2019-232940.

[3] Lim CS, Kaisbain N, Lim WJ. A Rare Combination: Dengue Fever Complicated With Guillain-Barre Syndrome. Cureus 2023. https://doi.org/10.7759/cureus.40957.

[4] Rajurkar RD, Patil DS, Jagzape M V. Pediatric Physiotherapeutic Approach for Guillain–Barre Syndrome Associated With Dengue Fever: A Case Report. Cureus 2023. https://doi.org/10.7759/cureus.46488.

[5] Mahashabde ML, Kumar L. Integrated Approach to Severe Dengue Complicated by Guillain-Barré Syndrome and Multi-organ Failure. Cureus 2024. https://doi.org/10.7759/cureus.63939.

[6] Langerak T, van Rooij I, Doornekamp L, Chandler F, Baptista M, Yang H, et al. Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections. Front Neurol 2021;12. https://doi.org/10.3389/fneur.2021.635753.

[7] Deschamps N, Nacher M, Chaumont H, Montcuquet A, Montagnac C, Succo T, et al. Temporal Association Between Dengue Outbreaks and Neurologic Autoimmune Diseases in French Guiana. Neurol Neuroimmunol Neuroinflamm 2025;12. https://doi.org/10.1212/NXI.0000000000200501.

[8] Ramos-Lopes J, Ribeiro J, Laço M, Alves C, Matos A, Costa C. A De Novo BSCL2 Gene S90L Mutation in a Progressive Tetraparesis with Urinary Dysfunction and Corpus Callosum Involvement. J Pediatr Genet 2021;10:253–8. https://doi.org/10.1055/s-0040-1713768.

[9] Bhushan B, Sardana V, Maheshwari D, Ojha P, Mohan S, Moon P, et al. Immune mediated neurological manifestations of dengue virus a study of clinico investigational variability, predictors of neuraxial involvement, and outcome with the role of immunomodulation. Neurol India 2018;66:1634–43. https://doi.org/10.4103/0028-3886.246273.

[10] Prateek, Sharma V, Paliwal N, Tak H. Dengue, Guillain-Barré syndrome, and cerebral infarction: A case of rare complication. Indian Journal of Critical Care Medicine 2019;23:533–5. https://doi.org/10.5005/jp-journals-10071-23285.

[11] Lynch RM, Mantus G, Encinales L, Pacheco N, Li G, Porras A, et al. Augmented zika and dengue neutralizing antibodies are associated with guillain-Barré syndrome. Journal of Infectious Diseases 2019;219:26–30. https://doi.org/10.1093/infdis/jiy466.

[12] Pari H, Amalnath SD, Dhodapkar R. Guillain-Barre Syndrome and Antibodies to Arboviruses (Dengue, Chikungunya and Japanese Encephalitis). Ann Indian Acad Neurol 2022;25:203–6. https://doi.org/10.4103/aian.aian_589_21.

[13] Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol 2019;15:671–83. https://doi.org/10.1038/s41582-019-0250-9.

[14] Jobran AfnanWM, Alawi RFF, AbuAlrob MA, Naser AM. Guillain–Barré Syndrome with MFS and AMSAN Variants: A Rare Case. Frontiers in Medical Case Reports 2022;03. https://doi.org/10.47746/fmcr.2022.3305.

[15] Kulkarni R, Pujari S, Gupta D. Neurological manifestations of dengue fever. Ann Indian Acad Neurol 2021;24:693–702. https://doi.org/10.4103/aian.AIAN_157_21.

[16] Yao J, Zhou R, Liu Y, Lu Z. Progress in Guillain–Barré syndrome immunotherapy—A narrative review of new strategies in recent years. Hum Vaccin Immunother 2023;19. https://doi.org/10.1080/21645515.2023.2215153.

[17] Bellanti R, Rinaldi S. Guillain-Barré syndrome: a comprehensive review. Eur J Neurol 2024;31. https://doi.org/10.1111/ene.16365.

[18] Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision. Eur J Neurol 2021;28:3556–83. https://doi.org/10.1111/ene.14959.

[19] Gawande I, Akhuj A, Samal S. Effectiveness of Physiotherapy Intervention in Guillain Barre Syndrome: A Case Report. Cureus 2024. https://doi.org/10.7759/cureus.52062.

[20] Dalugama C, Shelton J, Ekanayake M, Gawarammana IB. Dengue fever complicated with Guillain-Barré syndrome: A case report and review of the literature. J Med Case Rep 2018;12. https://doi.org/10.1186/s13256-018-1626-y.

[21] Pandey S, Garg R, Malhotra H, Kumar N, Uniyal R. Simultaneous occurrence of axonal Guillain–Barré syndrome in two siblings following dengue infection. Ann Indian Acad Neurol 2018;21:315. https://doi.org/10.4103/aian.aian_454_17.

[22] Mohiuddin O, Khan AA, Waqar SH Bin, Shaikh AT, Marufi MM, Jalees S, et al. Pharyngeal-cervical-brachial variant of guillain-barré syndrome: A case report of a rare complication following dengue-chikungunya co-infection. Pan African Medical Journal 2021;38. https://doi.org/10.11604/pamj.2021.38.356.28363.

[23] Kumar SS, Baitha U, Vyas S. An unusual case of acute motor axonal neuropathy (AMAN) complicating dengue fever. Drug Discov Ther 2021;15:214–7. https://doi.org/10.5582/ddt.2021.01063.

[24] Rayamajhi A, Rayamajhi S, Agrawal S, Gautam N. Unraveling the neurological intricacies: a rare case of Guillain-Barre syndrome in dengue fever. Oxf Med Case Reports 2024;2024. https://doi.org/10.1093/omcr/omae099.

[25] Hassan IN, Yaqub S, Ibrahim M, Aljaili G, Abuassa N. A rare neurological complication of dengue: Guillain-Barré Syndrome in a dengue fever patient. IDCases 2025;39. https://doi.org/10.1016/j.idcr.2025.e02160.